it's number 4,$アミリックス・ファーマシューティカルズ(AMLX.US)$all time low 6.5 USD... hope you can grow and get all FDA approval... it's profitable already... no 1.$バイオジェン(BIIB.US)$all time low 2 USD no 2.$ニューロクライン・バイオサイエンシス(NBIX.US)$all time low 1.9 USD no 3.$バイオヘブン(BHVN.US)$all time low 7 USD no5.$アルジェンX(ARGX.US)$all time low 17 USD And it's not bubble. Of course there are also, biotech companies which are failed. But I think if it's growing into a right directio...
$アルジェンX(ARGX.US)$ Clinical Disappointment in Phase 3 Study: Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF) Argenx's shares nosedived by 25% due to disappointing results from its Phase 3 study on efgartigimod subcutaneous (SC) for treating severe autoimmune diseases. The study aimed to address pemphigus vulgaris (PV) and pemphigus foliaceus (PF), causing skin blistering. Unexpectedly Strong Impact of Corticosteroids The primary setback was the ...
$アルジェンX(ARGX.US)$argenx Reports Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy $アジャイル・セラピューティクス(AGRX.US)$
72840290 : you dont pump much do you @Nasser09
Jaguar8 72840290:
Jaguar8 72840290: Spotted huh?
NASSER09スレ主 72840290: I have another App